Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
29 085 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32019R0831

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

XXXXXXXX XXXXXX (EU) 2019/831

xx dne 22. xxxxxx 2019,

xxxxxx xx xxxx xxxxxxx XX, III x X xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) x. 1223/2009 x xxxxxxxxxxxx přípravcích

(Xxxx x xxxxxxxx pro EHP)

XXXXXXXX XXXXXX,

x xxxxxxx na Smlouvu x xxxxxxxxx Xxxxxxxx unie,

x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) x. 1223/2009 xx dne 30. xxxxxxxxx 2009 x xxxxxxxxxxxx xxxxxxxxxxx (1), x xxxxxxx xx xx. 15 xxxx. 1, xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxx x xx. 31 xxxx. 1 xxxxxxxxx xxxxxxxx,

xxxxxxxx x xxxxx xxxxxxx:

(1)

Xxxxxxxx Evropského xxxxxxxxxx x Xxxx (ES) x. 1272/2008 (2) xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx látek xxxx xxxxx xxxxxxxxxxxxxx, xxxxxxxxxxx xxxx xxxxxxxxx xxx xxxxxxxxxx (CMR) xx xxxxxxx xxxxxxxxx posouzení Xxxxxx xxx posuzování xxxxx Xxxxxxxx agentury xxx chemické látky. Xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X, xxxxx XXX kategorie 1X xxxx xxxxx XXX xxxxxxxxx 2 x xxxxxxxxxx xx xxxxxx důkazů x xxxxxx xxxxxxxxxxxx CMR.

(2)

Xxxxxx 15 nařízení (XX) x. 1223/2009 zakazuje xxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxx části 3 xxxxxxx XX xxxxxxxx (ES) x. 1272/2008 (xxxxx XXX) jako xxxxx CMR xxxxxxxxx 1 X, kategorie 1X xxxx xxxxxxxxx 2. Xxxxx CMR xxxx xxxx xxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, xxxxx xxxx xxxxxxx podmínky xxxxxxxxx x xx. 15 odst. 1 xxxxx větě xxxx x xx. 15 xxxx. 2 druhém xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009. Xxxxx xxxxxxxxx xx xxxxxxx xxxxxxxx (XX) x. 1223/2009. Xxxxxxxx xxxxx Xxxx, včetně xxxxxx 15 xxxxxxxx (XX) x. 1223/2009, je oprávněn xxxxx Xxxxxx xxxx Xxxxxxxx xxxx.

(3)

V zájmu jednotného xxxxxxxxx zákazu xxxxx XXX v rámci xxxxxxxxx xxxx, xxxxxxxxx xxxxxx xxxxxxx zejména xxx xxxxxxxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxxxxxx xxxxxx, jakož x xxxxxxxxx vysoké xxxxxx xxxxxxx xxxxxxxx xxxxxx xx xxxxxxx látky XXX xxxx xxx xxxxxxxx xx xxxxxx xxxxxxxxxx xxxxx v příloze XX nařízení (XX) x. 1223/2009 x xxxxxxxx xxxxxx xx seznamů xxxxx xxxxxxxxxxxxx omezení xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx. Xxxxx xxxx splněny xxxxxxxx stanovené v čl. 15 xxxx. 1 druhé xxxx xxxx x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009, xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx xx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(4)

Xxxx xxxxxxxx xx xxxxxxxx na xxxxx, xxxxx xxxx xxxxx xxxxxxxx (XX) x. 1272/2008 xxxxxxxxxxxxx jako xxxxx XXX ke xxx 1. xxxxxxxx 2018, xxx xx xxxxx xxxxxxxxxxx nařízení Xxxxxx (XX) 2017/776 (3).

(5)

Xxxxx xxx x xxxxxx xxxxx XXX, pro xxx xxxx xxxxxxxxxx xxxxxx x xxxxxxxxx xxxxxxx v kosmetických xxxxxxxxxxx, xxxxxx xxxxxxxxx, xx xxxx splněny xxxxxxx xxxxxxxx xxxxxxxxxx x xx. 15 xxxx. 1 druhé xxxx nebo v čl. 15 xxxx. 2 druhém pododstavci xxxxxxxx (ES) x. 1223/2009. Xx se xxxx xxxxx Xxxxxxxxxx-15, Xxxxxxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx xxxxxxxx perborité x xxxxxxxxxxx xxxxxxx.

(6)

Xxxxx xxxxxxxxxx-3-xxxxxxxxxxxxxxxxx, xxxxx xxxxx xxxxx Xxxxxxxxxxx xxxxxxxxxxxx kosmetických xxxxxx (XXXX) zní Xxxxxxxxxx-15, xx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 31 xxxxxxx V nařízení (ES) x. 1223/2009 xxxx xxxxx xxxxxxxx v koncentraci xx 0,2 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Xxxxx Xxxxxxxxxx-15 xx směs cis- x xxxxx-xxxxxxx, xxxxx xxx-xxxxxx byl xxxxxxxxx Xxxxxx (XX) č. 790/2009 (4) xxxxxxxxxxxx jako xxxxx XXX xxxxxxxxx 2. Xxxx xxxxxxxxxxx se xxxxx použitelnou dne 1. xxxxxxxx 2010. V souladu x xx. 15 xxxx. 1 xxxxxx xxxxx xxxxxxxx (ES) x. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxxxxxx 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, byla-li xxxxxxxxxx Xxxxxxxx výborem xxx xxxxxxxxxx xxxxxxxxxxxx (xxxx xxx „XXXX“) x xxxxxxxx xxxx bezpečná pro xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx. Xx dnech 13. x 14. xxxxxxxx 2011 xxxxx VVBS xxxxxxx stanovisko týkající xx xxxxx Xxxxxxxxxx-15 (xxx-xxxxxx) (5), ve kterém xxxxxx x xxxxxx, xx xx xxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxx xxxxxxxxxx použití xxxxx Xxxxxxxxxx-15 v kosmetických xxxxxxxxxxx. X xxxxxxx xx klasifikaci xxx-xxxxxxx přítomného x xxxxx Xxxxxxxxxx-15 jako látky XXX kategorie 2 x xx stanovisko XXXX xx měla být xxxxx Quaternium-15 vyňata xx seznamu xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX uvedeného xxxxxxxx.

(7)

Xxxxx 2-xxxxxxxxxxxxx, xxxxx xxxxx xxxxx XXXX xxx Xxxxxxxxxxxxxxx, xx x xxxxxxxx xxxx uvedena x xxxxxxx 41 xxxxxxx X xxxxxxxx (ES) x. 1223/2009 xxxx xxxxx povolená x xxxxxxxxxxx xx 0,3 % x xxxxxxxxx připraveném k použití. Xxxxx Chloroacetamide byla xxxxx xxxxxxxx (XX) x. 1272/2008 klasifikována xxxx xxxxx XXX kategorie 2. Tato xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010, xxx je xxxxx, xxx se pro xxxxx stala xxxxxxxxxx xxxxxxxxxx xxxx XX, XXX x XX nařízení (XX) x. 1272/2008. V souladu x xx. 15 odst. 1 druhou xxxxx xxxxxxxx (XX) x. 1223/2009 může být xxxxx xxxxxxxxxxxxx xxxx xxxxxxxxx 2 xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xxxx-xx xxxxxxxxxx XXXX a shledána xxxx xxxxxxxx xxx xxxxxxx x xxxxxxxx přípravcích. Xxx 22. března 2011 vydal XXXX xxxxxxx stanovisko xxxxxxxx se látky Xxxxxxxxxxxxxxx (6), xx xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx dostupných xxxxx není xxxx xxxxx xxx použití x xxxxxxxxxxx xx 0,3 % xxxxxxxxxxxx x xxxxxxxxxxxx přípravcích xxx xxxxxxxxxxxx bezpečná. X xxxxxxx xx klasifikaci xxxxx Chloroacetamide xxxx xxxxx CMR xxxxxxxxx 2 a na stanovisko XXXX by xxxx xxx xxxx xxxxx xxxxxx xx xxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx přípravcích v příloze X xxxxxxxx (ES) x. 1223/2009 x xxxxxxxx xx xxxxxx xxxxx zakázaných x xxxxxxxxxxxx xxxxxxxxxxx v příloze XX xxxxxxxxx xxxxxxxx.

(8)

Látka xxxxxxxxxxxxx xx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 7 xxxxxxx III nařízení (XX) č. 1223/2009 xxxx xxxxx povolená v kosmetických xxxxxxxxxxx v koncentraci xx 35 % v přípravku xxxxxxxxxxx x xxxxxxx. Xxxxxxxxxxxxx byl xxxxx nařízení (ES) x. 1272/2008 xxxxxxxxxxxx xxxx xxxxx XXX kategorie 2. Tato xxxxxxxxxxx xx stala xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010. X xxxxxxx x xx. 15 odst. 1 xxxxxx větou nařízení (XX) č. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxxxxxx 2 xxxxxxx x xxxxxxxxxxxx přípravcích, xxxx-xx xxxxxxxxxx VVBS x xxxxxxxx xxxx bezpečná xxx xxxxxxx v takových xxxxxxxxxxx. Dne 11. xxxxxxxx 2012 xxxxx XXXX xxxxxxx xxxxxxxxxx xxxxxxxx xx xxxxx xxxxxxxxxxxxx (7). Xxx 25. xxxxxx 2015 vydal VVBS xxxx xxxxxxxxxx (8), které xxxx xxxxxxxxxx xxx 28. xxxxx 2015. X xxxxx xxxxxxxxxxx xxxxxxxxxx dospěl VVBS x xxxxxx, že xxxxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxx xx 35 % x xxxxxx xx xxxxx x xxxx xxxxxxx xx xxxxxxxx xxxxxx xxxx xxxxxxxxxx xx xxxxxxxx xxx spotřebitele. X xxxxxxx xx xxxxxxxxxxx xxxxxxxxxxxxxx jako xxxxx XXX xxxxxxxxx 2 x xx stanovisko VVBS x xxxxxxxx x xxxx, že xxxxxx xxxxx x xx xxxxxxxxxx XXXX posouzena xxxxx další xxxxxxx xxxxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx, xx xxxx xxxxx xxxx xxx xxxxxx xx seznamu xxxxx xxxxxxxxxxxxx xxxxxxx v příloze XXX xxxxxxxx (ES) x. 1223/2009 x xxxxxxxx na xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX uvedeného nařízení.

(9)

Xxxxx xxxxxxxxxxx je x xxxxxxxx xxxx uvedena x xxxxxxx 13 xxxxxxx III xxxxxxxx (XX) x. 1223/2009 xxxx látka xxxxxxxx x xxxxxxxxxxx pro xxxxxxx xxxxx v koncentraci do 5 % v přípravku xxxxxxxxxxx x xxxxxxx. X xxxxxxxx xxxx xx xxxx xxxxxxx x xxxxxxx 5 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 xxxx látka xxxxxxxx x xxxxxxxxxxx xxx xxxxx xxxxxxx x xxxxxxxxxxx xx 0,1 % x x xxxxxx xxxxxxxxxxx x xxxxxxxxxxx do 0,2 %. Xxxxxxxxxxx xxx klasifikován xxxx látka XXX xxxxxxxxx 1X nařízením Xxxxxx (XX) x. 605/2014 (9). Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxx 1. xxxxx 2016. V souladu s čl. 15 xxxx. 2 xxxxxx pododstavcem xxxxxxxx (XX) x. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X xxxx 1B v kosmetických xxxxxxxxxxx výjimečně použity, xxxxx jsou xxxx, xx byly xxxxxxxxxxxxx xxxx xxxxx XXX, xxxxxxx určité xxxxxxxx xxxxxx xxxxxxxx, xx xxxxxx x xxxxxxxxx xxxxx xxxxxx xxxxxxxxxxxx xxxxx, xx xxxx xxxxxx xxxxxx xx xxxxxx xxxxxxx kategorie xxxxxxxxx xx xxxxxx expozicí x xx xxxx tato xxxxx XXXX zhodnocena x xxxxxxxx jako bezpečná. Xxx 7. xxxxxxxxx 2014 xxxxxx XXXX xx xxxx xxxxxxxxxx (10) x xxxxxx, že „xxx tvrzení xxxx xxxxxxxx xxxxx xxxxx xxx xxxxxxxx xxxxxxx xxxxxxxxx xxx tvrzení xxxxx x xxxxxxxx xxxxxxxxxxx xxxxxx 2,2 % xxxxxxx xxxxxxxxxxxx“. Protože však xxxxxx xxxxxxxxx, xx xxxxxx x xxxxxxxxx žádné xxxxxx alternativní xxxxx xxx tvrzení nehtů, xxx xx xxx xxxxxxxxxxx xxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009. Xxxxxxxx x xxxx, xx xxxxxx podána žádost xx xxxx použití xxxxxxxxxxxx, měla xx xxx tato xxxxx xxxxxx xx seznamu xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx X xxxxxxxxx xxxxxxxx. Formaldehyd xx xxx xxx xxxxxx xxxxxxx xx xxxxxx xxxxx zakázaných x xxxxxxxxxxxx přípravcích x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009.

(10)

Xxxxxxxxxx xxxxxxxx perborité x xxxxxxxxxxx sodné patří xxxx xxxxx uvolňující xxxxxxx xxxxxx, xxxxx xxxx x xxxxxxxx xxxx xxxxxxx v položce 12 xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009. Xxxx xxxxx xxxx klasifikovány xxxx látky XXX xxxxxxxxx 1X xxxxxxxxx (XX) x. 790/2009. Tato xxxxxxxxxxx se xxxxx xxxxxxxxxxx xx xxx 1. xxxxxxxx 2010. Xx použití xxxxxx xxxxx x xxxxxxxxxx xxxxxxxxxxx x xxxxxxx vlasů xxxx xxxxxx xxxxxx x xxxxxxxxx xx. 15 xxxx. 2 xxxxxxx xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009. Xxx 22. xxxxxx 2010 xxxxxx XXXX xx xxxx stanovisku (11) x xxxxxx, že „xxxxxx xxxxxxx xxxxxx pro xxxxx, xxxxx xxxxxxxx xxxxxxx xxxxxx, xx xx xxxx xxxxxxxxx xx xxxxxxxxxx sodný x xxxxxxxx perboritou x xx xxxxxxx xxxxxxxxxxx xxxxxxx xxxx xxxxxx x xxxxxxxxxx xxxxxxxxxxx x xxxxxxx xxxxx x xxxxxxxxxxx nejvýše 3 % xx osobu nepředstavuje xxxxxx xxx zdraví xxxxxxxxxxxx“. Xxxxxxx xxxx xxxxxx xxxxxxxxx, xx xxxxxx k dispozici xxxxx xxxxxx xxxxxxxxxxxx xxxxx xxx xxxxx xxxxxxx xxxxx, sloučeniny kyseliny xxxxxxxxx x xxxxxxxxxxx xxxxx xx měly xxx xxxxxx ze xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX nařízení (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx látek xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(11)

Xxxxx xxx o určité xxxxx, xxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxx xxxxxxxx (XX) č. 1272/2008 a pro xxx byla podána xxxxxx x xxxxxxxxx čl. 15 xxxx. 1 xxxxx xxxx xxxxxxxx (XX) x. 1223/2009, xxxx stanoveno, že xxxxxxxx xxxxxxxxx v uvedeném xxxxxxxxxx xx splněna. Xx xx xxxx xxxxx Xxxxxxxxxxxxxxxx diphenylphosphine xxxxx, Xxxxxxxx a Polyaminopropyl xxxxxxxxx.

(12)

Xxxxx xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx, xxxxx xxxxx xxxxx XXXX zní Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx (XXX), xxxx v současné xxxx xx příloh xxxxxxxx (XX) x. 1223/2009 xxxxxxxx. Xxxx xxxxx xxxx xxxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 2 xxxxxxxxx Xxxxxx (XX) x. 618/2012 (12). Tato klasifikace xx stala xxxxxxxxxxx xxx 1. xxxxxxxx 2013. Xxx 27. xxxxxx 2014 xxxxx VVBS xxxxxxx stanovisko (13), v němž xxxxxx x xxxxxx, xx xxxxx XXX je xxxxxxxx při xxxxxxx xxxx xxxxxxxxx x xxxxxxxx xxxxx v koncentraci xx 5,0 %, xxxxx xx xxx o látku mírně xxxxxxxxxxxxxxx xxxx. Xxxxxxxx x xxxxxxxxxxxxxxxx xxxxxxx TPO xx xxxx x xxxxxxxx xxxxxx xxxxxxxx v důsledku xxxxx x xxxx xxx xxxxxxxx přípravku xx xxxxx xxxxxxxxx spotřebiteli xx používání XXX xxxx být omezeno xx xxxxxxxxxxxxx uživatele. X xxxxxxx na tyto xxxxxxxxxxx xx xxxxx XXX xxxx xxx xxxxxxxx xx xxxxxx xxxxx podléhajících omezení x xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009 xxx xxxxxxxxxxxxx použití x xxxxxxxxx xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxx 5 %.

(13)

Xxxxx 2-furaldehyd, xxxxx xxxxx podle XXXX zní Xxxxxxxx, xx používá jako xxxxx xxxx aromatická xxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x x xxxxxxxx době xxxx xxxxxxxx xx xxxxxx xxxxxxxx (XX) č. 1223/2009. Xxxx xxxxx byla xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2 xxxxx xxxxxxxx (XX) x. 1272/2008. Tato xxxxxxxxxxx xx xxxxx použitelnou xxxx 1. xxxxxxxxx 2010. Xxx 27. března 2012 xxxxxx XXXX xx svém xxxxxxxxxx (14) k závěru, že xxxxxxx látky Xxxxxxxx x xxxxxxxxxxx xx 10 xxx (0,001 %) x xxxxxxxxx xxxxxxxxxxx x xxxxxxx, xxxxxx xxxxxxxxx xxx xxxxx xxxxxxx, nepředstavuje riziko xxx xxxxxx xxxxxxxxxxxx. X xxxxxxx na klasifikaci xxxxx Xxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2 a na xxxxxxxxxx XXXX xx xxxxx Xxxxxxxx x xxxxxxxxxxx nejvýše 0,001 % měla být xxxxxxxx xx xxxxxx xxxxx podléhajících omezení x xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009.

(14)

Látka xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx (XXXX), xxxxx xxxxx xxxxx XXXX zní Xxxxxxxxxxxxxxx xxxxxxxxx, xx x xxxxxxxx xxxx xxxxxxx xx xxxxxxx xxxx xxxxxxxxxxx přísada x xxxxxxx 28 přílohy V nařízení (XX) x. 1223/2009 x xxxxxxxxxxx xxxxxxx 0,3 %. Tato xxxxx xxxx klasifikována xxxx xxxxx XXX xxxxxxxxx 2 nařízením Xxxxxx (XX) x. 944/2013 (15). Xxxx xxxxxxxxxxx xx xxxxx použitelnou xxx 1. xxxxx 2015. Xxx 18. xxxxxx 2014 xxxxxx XXXX xxxxxxxxxx (16), xx xxxxxx xxxxxx x xxxxxx, xx na xxxxxxx xxxxxxxxxx údajů xxxxx xxxxx XXXX xxxxxxxxx xx bezpečnou xxx xxxxxxxxxxxx, xxxxx xx x xxxxxxxxxxx xxxxxxx 0,3 % xxxxxxx jako xxxxxxxxxxx přísada x xxxxxxxxxx xxxxxxxxxxx přípravku. Xx xxxx stanovisku xxxx XXXX rovněž dospěl x xxxxxx, xx xxxxxxxx xxxxxxx by xxxxx xxx založeno na xxxxx xxxxxxxxxxx použití x/xxxx xxxxxxx, xxxxx xxx x xxxxxxxxx kosmetických xxxxxxxxx, x xx xxxx xxxxxxxxx xxxxxx xxxxxxxx xxxxxxxx týkající xx xxxxxxx reprezentativních xxxxxxxxxxxx xxxxxxxxx. Dne 7. xxxxx 2017 xxxxxx XXXX xxxx xxxxxxxxxx (17), ve xxxxxx xxxxxx k závěru, xx xx základě xxxxxxxxxxxx xxxxx xx použití XXXX xxxx xxxxxxxxxxx xxxxxxx xx xxxxx xxxxxxxxxxxx přípravcích x xxxxxxxxxxx xx 0,1 % xxxxxxxx xx xxxxxxxx, xxx xxxx použití ve xxxxxxxx xx xxxxxxxxxxxx. X xxxxxxx xx xxxxxxxxxxx XXXX xxxx xxxxx XXX xxxxxxxxx 2 x xx xxxx xxxxxxxxxx XXXX xx xxxxx XXXX xxxx být xxxxxxxx jako xxxxxxxxxxx xxxxxxx xx všech xxxxxxxxxxxx přípravcích, s výjimkou xxxxxxxx, xxx xxxxx xxxx x xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx xxx xxxxxxxxxx, x xxxxxxxxxxx xxxxxxx 0,1 %. Xxxxxxxx stanovené x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 xx xxxxx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(15)

Xxxxx xxx x xxxxxx xxxxxxx látek, xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxx xxxxxxxx (XX) x. 1272/2008, žádná xxxxxx xx xxxxxxxxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxxx xxxxxxxxxx. Tyto xxxxx xx xxxx xxx xxxxxxxx xx xxxxxx xxxxxxxxxx xxxxx x xxxxxxx XX xxxxxxxx (ES) x. 1223/2009 x xxxxxxxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx. Xx xx xxxx xxxx jiné xxxxxxxxx xxxxxxxxx xxxx, xxxxx xxxx v současné xxxx xxxxxxx x xxxxxxxxx 1x x 1x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009.

(16)

Xxxxxxx xxxxxxxxxx xxxx, které xxxx v současné xxxx xxxxxxx x xxxxxxxxx 1x x 1x přílohy XXX xxxxxxxx (XX) č. 1223/2009, x xxxxxxxxxx-xxxxxxxxxxxxx byly xxxxxxxxx (XX) x. 790/2009 xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1X. Tato xxxxxxxxxxx se stala xxxxxxxxxxx ke xxx 1. xxxxxxxx 2010. V souladu x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009 xxxxx xxx látky xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X xxxx 1X x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx použity, xxxxx xxxx poté, xx byly xxxxxxxxxxxxx xxxx xxxxx XXX, xxxxxxx xxxxxx podmínky. Xxx 22. června 2010 vydal XXXX xxxxxxxxxx (18), v němž xxxxxx x xxxxxx, xx xxxxxxx xxxxxxxxxx boru, xxxxx jsou x xxxxxxxx xxxx xxxxxxx v položkách 1x a 1b přílohy XXX zmíněného nařízení, xxxx pro xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xx xxxxxxxx podmínek bezpečné. Xxxxxxx xxxxxx podána xxxxxx xx xxxxxx xxxxxxx x xxxxxx stanoveno, xx xxxxxx x xxxxxxxxx xxxxx xxxxxx alternativní xxxxx xxx xxxxx xxxxxxxxxxxx použití xxxxxxxxx x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009, xxxx xx xxx xxxxxxx xxxxxxxxxx xxxx vyňaty xx seznamu látek xxxxxxxxxxxxx xxxxxxx x xxxxxxx XXX xxxxxxxxx nařízení x xxxxxxxx na seznam xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze XX xxxxxxxx (ES) č. 1223/2009. Xxxxx xxx x xxxxxxxxxx-xxxxxxxxxxxxx, xxxxxx podána žádost xx xxxxxx použití x XXXX xx xxxxxxxxx xxxx xxxxxxxxx. Xxxxxxx xxxxx by xxxxx xxxx xxx xxxxxxxx xx xxxxxx látek xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx XX xxxxxxxx (XX) č. 1223/2009.

(17)

Xxxxxxxxxx čl. 31 xxxx. 1 xxxxxxxx (XX) x. 1223/2009 xxxxxxx, že xxxxxxxxxxx-xx xxxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx riziko pro xxxxxx xxxxxx, xxxxx xxxxxxxx xxxxx xx xxxxxx Společenství, xxxx Xxxxxx xx konzultaci x XXXX xxxxxxxxxxxxx způsobem xxxxxx xxxxxxx XX xx XX uvedeného xxxxxxxx. Xxxxxx xxxxxxxxxxxx XXXX xxxxxxx xxxxxxxxxxx xxxxxxxx xxxxx, xxxxx xxxx x xxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx xxxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 X, 1X xxxx 2. Xx xx xxxx xxxxxxxx xxxxxxxxx xxxx, xxxxx x xxxxx xxxxxxxxxxxxxxx x xxxxxxxxxxxxxx.

(18)

Xxxxxxx xxxxxxxxxx boru, v současné xxxx xxxxxxx x xxxxxxxxx 1x x 1x xxxxxxx XXX nařízení (ES) x. 1223/2009, xxxx xxx xxxxxxxxxx uvedené x 16. xxxx xxxxxxxxxx, xxxxxx xxxxxxxxxxxxx xxxx látky XXX. Xxx 12. xxxxxxxx 2013 xxxxx XXXX stanovisko xxxxxxxx xx boritanů, xxxxxxxxxxxxx x xxxxxxxxxxxx (19), xx xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx xxxxx, xxxxxx xxxx xxxxxxx soli xxxx xxxxxx xxxxxxxx xxxxxx, xxxx xx MEA-borát, XXXX-xxxxxxx, xxxxxxx draselný, xxxxxxxxxxxxxxx-xxxxx a boritan xxxxxxxxx, xxxxxxxxx xx vodných xxxxxxxxx xx xxxxxxxx xxxxxxx, x xxxxx xx xx xxxxxx xxxxxxx xxxxxx pro kyselinu xxxxxxx xxxx xxxxxxxxx xx xxxxx skupinu xxxxxxxx, xxxxxxxxxxxxx x xxxxxxxxxxxx. Xxxxxxxx xxxxxx byla xxxxxxxxx (XX) č. 790/2009 xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1X. Xxxx xxxxxxxxxxx se xxxxx použitelnou ke xxx 1. prosince 2010. Xxxx xxxxxxx xxxxxxxx, tetraboritanů x xxxxxxxxxxxx, x xxxxxxxx xxxxx x xxxxxxx xxxxxxx, které xxxx xxxxxxxxxxxxx xxxx xxxxx XXX, xxxxxx xxxx ostatní xxxx xxxx xxxxxx xxxxxxxx xxxxxx xx xxxx xxx x xxxxxxx xx xxxxxxxxxx XXXX xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx v příloze XXX nařízení (XX) x. 1223/2009 x xxxxxxxx na xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(19)

Látka xxxxxxxxxxxxxxx xx v současné xxxx uvedena xx xxxxxxx v položce 5 xxxxxxx V nařízení (ES) x. 1223/2009, avšak xx xxxxxx xx xxxxxxxxxxxx xxxxxx klasifikována xxxx xxxxx XXX. Xxxxx xxxxxxxxxxxxxx není x xxxxxxxx xxxx xx příloh xxxxxxxx (ES) č. 1223/2009 xxxxxxxx. Xx xxxxx 26. x 27. xxxxxx 2012 xxxxxx XXXX stanovisko xxxxxxxx xx xxxxxxxxxxxxxxx (20), ve xxxxxx stanovil, xx xxxxxxxxxxxxxx xx xx xxxx xxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxxx, xxx xxxx x xxxx xxxxxxx xx xxxxxxxxxxx xx xxxxxxx xxxxxxxxx, a že xxxxxxxxxxxxxxx může depolymerizovat, xxx xxxx k jeho xxxxxxx na xxxxxxxxxxx xxxxxxxx xxxx sušením. X xxxxxxx na xxxxxxxxxx XXXX xxxxxxxx potenciální xxxxxx pro lidské xxxxxx vyplývající x xxxxxxx xxxxxx xxxxx x xxxxxxxxxxxx xxxxxxxxxxx. Paraformaldehyd by xxxxx měl být xxxxx xx xxxxxxx xxxxxxxxxxxxx xxxxxx povolených x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxxxxxxxxx x xxxxxxxxxxxxxx xx xxxx xxx xxxxxxxx xx xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx II uvedeného xxxxxxxx.

(20)

Xxxxxxxx (XX) x. 1223/2009 xx xxxxx xxxx xxx xxxxxxxxxxxxx způsobem xxxxxxx.

(21)

Xxxxxxxx stanovená xxxxx xxxxxxxxx xxxx v souladu xx stanoviskem Stálého xxxxxx xxx kosmetické xxxxxxxxx,

XXXXXXX TOTO XXXXXXXX:

Xxxxxx 1

Xxxxxxx XX, III x X xxxxxxxx (XX) č. 1223/2009 xx mění x xxxxxxx x xxxxxxxx tohoto nařízení.

Xxxxxx 2

Xxxx xxxxxxxx vstupuje x xxxxxxxx xxxxxxxx dnem xx xxxxxxxxx x Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.

Xxxx nařízení je xxxxxxx x xxxxx xxxxxxx x xxxxx použitelné ve xxxxx xxxxxxxxx xxxxxxx.

X Xxxxxxx xxx 22. xxxxxx 2019.

Za Xxxxxx

xxxxxxxx

Xxxx-Xxxxxx XXXXXXX

(1)&xxxx;&xxxx;Xx.&xxxx;xxxx.&xxxx;X&xxxx;342, 22.12.2009, s. 59.

(2)  Nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx směrnic 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx nařízení (XX) x.&xxxx;1907/2006 (Úř. věst. L 353, 31.12.2008, x.&xxxx;1).

(3)  Nařízení Xxxxxx (XX) 2017/776 xx xxx 4.&xxxx;xxxxxx&xxxx;2017, xxxxxx se xxx účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx a balení xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;116, 5.5.2017, s. 1).

(4)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (ES) x.&xxxx;790/2009 ze xxx 10.&xxxx;xxxxx&xxxx;2009, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, označování a balení xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;235, 5.9.2009, x.&xxxx;1).

(5)&xxxx;&xxxx;XXXX/1344/10, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_077.xxx.

(6)  SCCS/1360/10, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_053.pdf.

(7)  SCCS/1408/11, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_118.xxx

(8)&xxxx;&xxxx;XXXX/1547/15, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_170.xxx

(9)&xxxx;&xxxx;Xxxxxxxx Komise (XX) x.&xxxx;605/2014 xx dne 5.&xxxx;xxxxxx&xxxx;2014, kterým xx xxx xxxxx xxxxxxxx xxxxxxxxxxxx výrazů xxxxxxxxxx xx xxxxxxxxxxxxx x&xxxx;xxxxxxxxxx xxxxxxxxx x&xxxx;xxxxxxxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx pokroku xxxx xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;167, 6.6.2014, x.&xxxx;36).

(10)&xxxx;&xxxx;XXXX/1538/14, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_164.pdf

(11)&xxxx;&xxxx;XXXX/1345/10, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_031.xxx

(12)  Nařízení Xxxxxx (XX) x.&xxxx;618/2012 xx dne 10.&xxxx;xxxxxxxx&xxxx;2012, kterým se xxx xxxxx přizpůsobení xxxxxxx-xxxxxxxxxxx pokroku xxxx xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (ES) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí (Xx.&xxxx;xxxx.&xxxx;X&xxxx;179, 11.7.2012, x.&xxxx;3).

(13)&xxxx;&xxxx;XXXX/1528/14, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_149.pdf.

(14)&xxxx;&xxxx;XXXX/1461/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_083.xxx

(15)  Nařízení Xxxxxx (XX) x.&xxxx;944/2013 ze dne 2.&xxxx;xxxxx&xxxx;2013, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx mění xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí (Úř. věst. L 261, 3.10.2013, x.&xxxx;5).

(16)&xxxx;&xxxx;XXXX/1535/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_157.xxx

(17)&xxxx;&xxxx;XXXX/1581/16, https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_204.pdf

(18)&xxxx;&xxxx;XXXX/1249/09, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_027.xxx

(19)&xxxx;&xxxx;XXXX/1523/13, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_146.xxx

(20)&xxxx;&xxxx;XXXX/1483/12, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_097.pdf

XXXXXXX

1)&xxxx;&xxxx;&xxxx;

Xxxxxxx XX xx xxxx xxxxx:

x)

xxxxxxxx xx xxxx xxxxxxx, které xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx látky

Chemický xxxxx/XXX

Xxxxx CAS

Číslo XX

x

x

x

x

„1385

Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX)

51229-78-8

426-020-3

1386

Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (cis-CTAC), quaternium-15

51229-78-8

426-020-3

1387

2-Chloracetamid

79-07-2

201-174-2

1388

Oktamethylcyklotetrasiloxan

556-67-2

209-136-7

1389

Dichlormethan; xxxxxxxxxxxxxxx

75-09-2

200-838-9

1390

2,2′-((3,3′,5,5′-xxxxxxxxxxx-(1,1′-xxxxxxx)-4,4′-xxxx)-xxx(xxxxxxxxxxx))-xxxxxxxxx

85954-11-6

413-900-7

1391

Xxxxxxxxxxx; ethanal

75-07-0

200-836-8

1392

1-Cyklopropyl-6,7-difluor-4-oxo-1,4-dihydrochinolin-3-karboxylová xxxxxxxx

93107-30-3

413-760-7

1393

X-xxxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxxx-2-xx

872-50-4

212-828-1

1394

Xxxxxxxxxxxx; xxxx boritý

1303-86-2

215-125-8

1395

Kyselina xxxxxx [1]

Xxxxxxxx xxxxxx [2]

10043-35-3 [1]

11113-50-1 [2]

233-139-2 [1]

234-343-4 [2]

1396

Xxxxxxxx, tetraboritany, xxxxxxxxxxxx a xxxx x xxxxxx xxxxxxxx xxxxxx, včetně:

Oktaboritan xxxxxxx xxxxxxxxxxx [1]

12280-03-4 [1]

234-541-0 [1]

2-xxxxxxxxxxxx, xxxxxxxxx s xxxxxxxxx boritou [2]

10377-81-8 [2]

233-829-3 [2]

(2-hydroxypropyl)amoniumdihydrogenorthoboritan [3]

68003-13-4 [3]

268-109-8 [3]

Boritan xxxxxxxx, xxxxxxxx xxx kyseliny xxxxxx [4]

12712-38-8 [4]

603-184-6 [4]

Xxxxxxxxxxxxxxx-xxxxx [5]

-[5]

— [5]

Xxxxxxx xxxxxxxxx [6]

1332-07-6 [6]

215-566-6 [6]

Xxxxxxx sodný, xxxxxxxxxxxx xxxxxxx xxxxxxx; xxxxx xxx xxxxxxxx borité [7]

1330-43-4 [7]

215-540-4 [7]

Xxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxx [8]

12267-73-1 [8]

235-541-3 [8]

Xxxxx xxx xxxxxxxx xxxxxxxxxxx [9]

13840-56-7 [9]

237-560-2 [9]

Tetraboritan disodný xxxxxxxxxx; borax dekahydrát [10]

1303-96-4 [10]

215-540-4 [10]

Tetraboritan xxxxxxx xxxxxxxxxxx; xxxxx xxxxxxxxxxx [11]

12179-04-3 [11]

215-540-4 [11]

1397

Xxxxxxxxxx xxxxx [1]

peroxometaboritan xxxxx; xxxxxxxxxxxxx xxxxx [2]

15120-21-5 [1]

239-172-9 [1]

7632-04-4 [2]

10332-33-9 [2]

10486-00-7[2]

231-556-4 [2]

1398

Xxxxxxxx xxxxxxxxx (H3BO2(O2)), xxxxxxxxx xxx, xxxxxxxxx [1]

13517-20-9 [1]

239-172-9 [1]

xxxxxxxx xxxxxxxxx, xxxxx sůl, xxxxxxxxxxx [2]

37244-98-7 [2]

234-390-0 [2]

xxxxxxxx xxxxxxxxx (XXX(X2)), xxxxx xxx, tetrahydrát peroxyboritan xxxxx xxxxxxxxxx [3]

10486-00-7 [3]

231-556-4 [3]

1399

Kyselina perboritá, xxxxx sůl [1]

11138-47-9 [1]

234-390-0 [1]

xxxxxxxx xxxxxxxxx, xxxxx sůl, xxxxxxxxxx [2]

12040-72-1 [2]

234-390-0 [2]

xxxxxxxx xxxxxxxxx (XXX(X2)), xxxxx xxx, xxxxxxxxxx [3]

10332-33-9 [3]

231-556-4 [3]

1400

Xxxxxxxxxx-xxxxxxxxxxxxx

75113-37-0

401-040-5

1401

Xxxxxxxxxxxxxxxxxx nikelnatý

14708-14-6

238-753-4

1402

Mankozeb (XXX); xxxxxx-X,X′-xxxxxxxxxx(xxxxxxxxxxxxxx), polymerní xxxxxxx se zinečnatou xxxx

8018-01-7

616-995-5

1403

Xxxxx (ISO); mangan-N,N′-ethylenbis(dithiokarbamát) (xxxxxxxxx)

12427-38-2

235-654-8

1404

Xxxxxxxxxxx (ISO); ethyl-N-[({[(2,2-dimethyl-2,3-dihydro-1-benzofuran-7-yl)oxy]karbonyl} xxxxxxxxxxx)xxxxxxxx]-X-xxxxxxxxx-β-xxxxxxxx

82560-54-1

617-356-3

1405

X-xxxxxxxx-X-xxxxxx karbonylthiokarbamát

103122-66-3

434-350-4

1406

Chlorprofam (XXX); xxxxxxxxx-3-xxxxxxxxxxxxxxx

101-21-3

202-925-7

1407

Xxxxx-X-(xxxxxxxxxxxxxx)xxxxxxxxxxxx

109202-58-6

432-750-3

1408

Xxxxxxxxxxxxxxx-xxxxxx

13465-08-2

236-691-2

1409

(4-Xxxxxxxxxxx)[3-(3-xxxxxx-4-xxxxxxxxxx)xxxxxx]xxxxxxxxxxxxx

105024-66-6

405-020-7

1410

Xxxxx (ISO); diethyl-N-[fenyl(kyan)methyl]fosforamidát

14816-18-3

238-887-3

1411

Glufosinát xxxxxx (ISO); amonium-2-amino-4-[hydroxy (xxxxxx)xxxxxxxx]xxxxxxxx

77182-82-2

278-636-5

1412

Xxxxxxx xxxx: xxxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxx-xxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx

—

435-960-3

1413

(4-Xxxxxxxxxx)xxxxxxxxx xxxxxxxx

86552-32-1

420-450-5

1414

Xxxxxxx xxxx: 4,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx; 4,8-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx; 5,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx

170016-25-8

427-050-1

1415

Xxxxxxxxxxx didraselno-hexatitaničitý(K2Ti6O13)

12056-51-8

432-240-0

1416

Octan kobaltnatý

71-48-7

200-755-8

1417

Dusičnan xxxxxxxxxx

10141-05-6

233-402-1

1418

Xxxxxxxxx xxxxxxxxxx

513-79-1

208-169-4

1419

Xxxxxxx xxxxxxxxx

7718-54-9

231-743-0

1420

Xxxxxxxx xxxxxxxxx [1]

13138-45-9 [1]

236-068-5 [1]

xxxxxxxx xxxxxxx, xxx xxxxx [2]

14216-75-2 [2]

238-076-4 [2]

1421

Xxxxxxx kamínek (lech)

69012-50-6

273-749-6

1422

Bahna x xxxx z xxxxxxxxxxxxxx rafinace mědi, xxxxxxx xxxx, x xxxxxxx síranu nikelnatého

92129-57-2

295-859-3

1423

Bahna x kaly z xxxxxxxxxxxxxx rafinace mědi, xxxxxxx mědi

94551-87-8

305-433-1

1424

Chloristan xxxxxxxxx; xxxxxxxx xxxxxxxxx, xxxxxxxxx xxx

13637-71-3

237-124-1

1425

Xxxxx xxxxxxxxxx-xxxxxxxxx [1]

13842-46-1 [1]

237-563-9 [1]

xxxxx xxxxxxxx-xxxxxxxxx [2]

15699-18-0 [2]

239-793-2 [2]

1426

Xxxx-xxx(xxxxxxxxxx); xxxx-xxxxxxxx

13770-89-3

237-396-1

1427

Xxxxxxxxxxxxxxxxxx nikelnatý

14708-14-6

238-753-4

1428

Nikl-diformiát [1]

3349-06-2 [1]

222-101-0 [1]

xxxxxxxx kyselina, xxx xxxxx [2]

15843-02-4 [2]

239-946-6 [2]

xxxxxxxx xxxxxxxx, xxx mědi x xxxxx [3]

68134-59-8 [3]

268-755-0 [3]

1429

Xxxx-xxxxxxxx [1]

373-02-4 [1]

206-761-7 [1]

xxxx-xxxxxx [2]

14998-37-9 [2]

239-086-1 [2]

1430

Xxxx(XX)-xxxxxxxxx

553-71-9

209-046-8

1431

Xxxx-xxx(4-xxxxxxxxxxxxxxxxxx)

3906-55-6

223-463-2

1432

Xxxx(XX)-xxxxxxx; xxxx(XX)-xxxxxxx

2223-95-2

218-744-1

1433

Xxxx-xxxxxxxx

16039-61-5

—

1434

Xxxx(XX)-xxxxxxxx

4995-91-9

225-656-7

1435

Xxxxxxx xxxxxxxxx [1]

10028-18-9 [1]

233-071-3 [1]

bromid xxxxxxxxx [2]

13462-88-9 [2]

236-665-0 [2]

xxxxx nikelnatý [3]

13462-90-3 [3]

236-666-6 [3]

xxxxxxx xxxxxxxx-xxxxxxxxx [4]

11132-10-8 [4]

- [4]

1436

Hexafluorokřemičitan xxxxxxxxx

26043-11-8

247-430-7

1437

Xxxxxxx xxxxxxxxx

15060-62-5

239-125-2

1438

Xxxxxxxxxxxxxxxxxxx nikelnatý [1]

14332-34-4 [1]

238-278-2 [1]

xxx(xxxxxxxxxxxxxxxxxxxxx) xxxxxxxxx [2]

18718-11-1 [2]

242-522-3 [2]

xxxxxxxxxxxxxxxx nikelnatý [3]

10381-36-9 [3]

233-844-5 [3]

xxxxxxxxxxxxx xxxxxxxxxxx [4]

14448-18-1 [4]

238-426-6 [4]

bis(fosfornan) xxxxxxxxx [5]

14507-36-9 [5]

238-511-8 [5]

xxxxxxxxxxxx niklu [6]

36026-88-7 [6]

252-840-4 [6]

kyselina fosforečná, xxx xxxxxxx x xxxxx [7]

17169-61-8 [7]

- [7]

xxxxxxxx xxxxxxxxxxxx, nikelnatá xxx [8]

19372-20-4 [8]

— [8]

1439

Xxxxxxxxxxxxxxxxxxxxx xxxxxxxx-xxxxxxxxx

74195-78-1

—

1440

Xxxxxx xxxxxxxxx

557-19-7

209-160-8

1441

Xxxxxxx xxxxxxxxx

14721-18-7

238-766-5

1442

Xxxxxxxxxx nikelnatý [1]

21784-78-1 [1]

244-578-4 [1]

orthokřemičitan xxxxxxxxxxx [2]

13775-54-7 [2]

237-411-1 [2]

křemičitan xxxxxxxxx (3:4) [3]

31748-25-1 [3]

250-788-7 [3]

xxxxxxxx xxxxxxxxx, xxx niklu [4]

37321-15-6 [4]

253-461-7 [4]

xxxxxxxxxxx-xxxxxxxxxx [xxxxxxxxxxxxx(4-)]xxxxxxxxxxxx(3-)xxxxxxxx [5]

12519-85-6 [5]

235-688-3 [5]

1443

Xxxxxxxxxxxxxxxxxxxxx xxxxxxxxxxx

14874-78-3

238-946-3

1444

Xxxxxxxxxxxxx xxxxxxxxxxxx; arseničnan xxxxxxxxx

13477-70-8

236-771-7

1445

Xxxx(XX)-xxxxxx [1]

547-67-1 [1]

208-933-7 [1]

xxxxxxxxx kyselina, sůl xxxxx [2]

20543-06-0 [2]

243-867-2 [2]

1446

Xxxxxxxx xxxxxxxxx

12142-88-0

235-260-6

1447

Xxxxxxxxxxx triniklu

12137-12-1

—

1448

Bisarsenitan xxxxxxxxxxxx

74646-29-0

—

1449

Xxxx xxxxxxxx s xxxxxxx xxxxx a xxxxxxx; C.I. xxxxxxxxxx xxxx 25; C.I. 77332 [1]

68186-89-0 [1]

269-051-6 [1]

xxxxxx xxxxxxxxxx-xxxxxxxxx [2]

58591-45-0 [2]

261-346-8 [2]

xxxx kobaltu x niklu [3]

12737-30-3 [3]

620-395-9 [3]

1450

Trioxid nikelnato-cíničitý; xxxxxxxxx xxxxxxxxx

12035-38-0

234-824-9

1451

Xxxxxxxx xxxxxxxxx-xxxxxxxxxx

15780-33-3

239-876-6

1452

Xxxxxxxxxxxxxx xxxxxxxxx

13689-92-4

237-205-1

1453

Xxxxxxxxx xxxxxxxxx

15586-38-6

239-646-5

1454

Xxxxxxxxxxx xxxxxxxxx

10101-96-9

233-263-7

1455

Xxxxxxx xxxxxxxxx

1314-05-2

215-216-2

1456

Xxxxxxxx xxxxxxxxx, xxx xxxxx x niklu

68130-19-8

—

1457

Diarsenid xxxxx [1]

12068-61-0 [1]

235-103-1 [1]

xxxxxxx xxxxx [2]

27016-75-7 [2]

248-169-1 [2]

1458

Xxxxxx xxxxx xxxxxxxx s obsahem xxxxx, barya x xxxxxx; X.X. xxxxxxxxxx xxxx 157; C.I. 77900

68610-24-2

271-853-6

1459

Xxxxxxxxxx xxxxxxxxx [1]

67952-43-6 [1]

267-897-0 [1]

xxxxxxxxx xxxxxxxxx [2]

14550-87-9 [2]

238-596-1 [2]

xxxxx-xxxxxxxx-xxxxxx, xxxxxxxxx xxx [3]

71720-48-4 [3]

275-897-7 [3]

1460

Nikl(II)-trifluoracetát [1]

16083-14-0 [1]

240-235-8 [1]

nikl(II)-propionát [2]

3349-08-4 [2]

222-102-6 [2]

xxxx-xxx(xxxxxxxxxxxxxx) [3]

39819-65-3 [3]

254-642-3 [3]

xxxx(XX)-xxxxxxxx-xxxxxx [4]

18721-51-2 [4]

242-533-3 [4]

xxxxxxxxx xxxxxxxx, xxxxxxxxxxxxxxx xxx [5]

18283-82-4 [5]

242-161-1 [5]

citronová xxxxxxxx, xxx niklu [6]

22605-92-1 [6]

245-119-0 [6]

nikl-[bis(2-ethylhexanoát)] [7]

4454-16-4 [7]

224-699-9 [7]

2-xxxxxxxxxxxxx kyselina, xxx xxxxx [8]

7580-31-6 [8]

231-480-1 [8]

dimethylhexanová xxxxxxxx, xxx xxxxx [9]

93983-68-7 [9]

301-323-2 [9]

nikl(II)-isooktanoát [10]

29317-63-3 [10]

249-555-2 [10]

xxxxxxxxxxx xxxxxxxx, xxx niklu [11]

27637-46-3 [11]

248-585-3 [11]

xxxx-xxxxxxxxxxxxx [12]

84852-37-9 [12]

284-349-6 [12]

nikl(II)-neononanoát [13]

93920-10-6 [13]

300-094-6 [13]

xxxx(XX)-xxxxxxxxxxx [14]

85508-43-6 [14]

287-468-1 [14]

nikl(II)-neodekanoát [15]

85508-44-7 [15]

287-469-7 [15]

xxxxxxxxxxx xxxxxxxx, xxx xxxxx [16]

51818-56-5 [16]

257-447-1 [16]

xxxx(XX)-xxxxxxxxxxxxx [17]

93920-09-3 [17]

300-093-0 [17]

bis(D-glukonato-O 1,X 2)xxxx [18]

71957-07-8 [18]

276-205-6 [18]

xxxx-xxx(3,5-xx-xxxx-xxxxx-4-xxxxxxxxxxxxxx (1:2) [19]

52625-25-9 [19]

258-051-1 [19]

nikl(II)-palmitát [20]

13654-40-5 [20]

237-138-8 [20]

(2-ethylhexanoato-O)(isononanoato-O)nikl [21]

85508-45-8 [21]

287-470-2 [21]

(isononanoato-O)(isooktanoato-O)nikl [22]

85508-46-9 [22]

287-471-8 [22]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [23]

84852-35-7 [23]

284-347-5 [23]

(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [24]

84852-39-1 [24]

284-351-7 [24]

(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [25]

85135-77-9 [25]

285-698-7 [25]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [26]

85166-19-4 [26]

285-909-2 [26]

(isodekanoato-O)(isononanoato-O)nikl [27]

84852-36-8 [27]

284-348-0 [27]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [28]

85551-28-6 [28]

287-592-6 [28]

mastné xxxxxxxx, X6-19 xxxxxxxxxx, xxxx xxxxx [29]

91697-41-5 [29]

294-302-1 [29]

xxxxxx kyseliny, X8-18 x xxxxxxxxxx X18, xxxx xxxxx [30]

84776-45-4 [30]

283-972-0 [30]

xxxxxxxx-2,7-xxxxxxxxxxx kyselina, xxxxxxxxx sůl [31]

72319-19-8 [31]

[31]

1461

Xxxxxxxxx nikelnatý [1]

7757-95-1 [1]

231-827-7 [1]

trioxid xxxxxxxxx-xxxxxxxxxxx [2]

15851-52-2 [2]

239-967-0 [2]

tetraoxid xxxxxxxxx-xxxxxxxxx [3]

15852-21-8 [3]

239-974-9 [3]

xxxxxxxxxxx-xxxxxxxx-xxxx molybdenu a xxxxx [4]

68130-36-9 [4]

268-585-7 [4]

1462

Xxxxx xxxxx (XxX) [1]

12007-00-0 [1]

234-493-0 [1]

borid xxxxxxx [2]

12007-01-1 [2]

234-494-6 [2]

xxxxx xxxxxxxx [3]

12007-02-2 [3]

234-495-1 [3]

xxxxx niklu [4]

12619-90-8 [4]

235-723-2 [4]

silicid xxxxxxxxx [5]

12059-14-2 [5]

235-033-1 [5]

xxxxxxxxx xxxxx [6]

12201-89-7 [6]

235-379-3 [6]

xxxxxx xxxxxxx [7]

12035-64-2 [7]

234-828-0 [7]

fosfid xxxxx x xxxx [8]

65229-23-4 [8]

[8]

1463

Tetraoxid nikelnato-dihlinitý [1]

12004-35-2 [1]

234-454-8 [1]

trioxid xxxxxxxxx-xxxxxxxxxx [2]

12035-39-1 [2]

234-825-4 [2]

xxxx xxxxx x xxxxxx [3]

12653-76-8 [3]

235-752-0 [3]

xxxxxxxx xxxxxxxxx-xxxxxxxxxxx [4]

52502-12-2 [4]

257-970-5 [4]

xxxxxxxx xxxxxxxxxx-xxxxxxxxx-xxxxxxxxxxxxx [5]

68016-03-5 [5]

268-169-5 [5]

trioxid xxxxxxxxx-xxxxxxxxxxx [6]

70692-93-2 [6]

274-755-1 [6]

xxxxxxxxx nikelnato-molybdenový [7]

14177-55-0 [7]

238-034-5 [7]

tetraoxid xxxxxxxxx-xxxxxxxxxx [8]

14177-51-6 [8]

238-032-4 [8]

xxxxxx, xxxxxxx xxxxx [9]

68515-84-4 [9]

271-112-7 [9]

xxxxxx xxxxxxxx-xxxxxxxxx [10]

12031-65-1 [10]

620-400-4 [10]

xxxx xxxxxxxxx a xxxxx [11]

12673-58-4 [11]

— [11]

1464

Xxxxxx-xxxxxxx-xxxx-xxxx

—

442-750-5

1465

Xxxx xxxxxxxxxxx

1313-27-5

215-204-7

1466

Xxxxxxxxxxxxxxxxxxx (DBTC)

683-18-1

211-670-0

1467

4,4′-bis(N-karbamoyl-4-methylbenzensulfonamid) xxxxxxxxxxxxx

151882-81-4

418-770-5

1468

Xxxxxxxxxxxxxxx; (2-xxxxx)xxxxxxxx

98-00-0

202-626-1

1469

1,2-Xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx; 4-xxxxxxxxxxxxxxxxxxxxxxx

106-87-6

203-437-7

1470

6-Xxxxxxxxxxxxxxx-1-xx-xxxxxxxxxxxxxxx

27610-48-6

429-960-2

1471

2-(2-Xxxxxxxxxxxxxxx)xxxxxxx (XXXX)

111-41-1

203-867-5

1472

1,2-Xxxxxxxxxxxxx

629-14-1

211-076-1

1473

(2,3-Xxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

3033-77-0

221-221-0

1474

1-(2-Xxxxx-5-xxxxxxxxxx)-2,2,2-xxxxxxxxxxxxx-1,1-xxxx-xxxxxxxxxxxx

214353-17-0

433-580-2

1475

(X)-3-[1-[4-[2-(xxxxxxxxxxxxx)xxxxxx]xxxxx]-2-xxxxxxxx-1-xxxx]xxxxx

82413-20-5

428-010-4

1476

4,4′-[1,3-Xxxxxxxxxx(1-xxxxxxxxxxxxx)]xxxxxxx

13595-25-0

428-970-4

1477

2-Xxxxx-6-xxxxxxxxxx

2040-90-6

433-890-8

1478

5-Xxxx-xxxxx-2-xxxxxxxxxxxx-1-xxxxx

—

444-970-7

1479

2-Xxxxxxx-3-xxxxxxx-5-xxxxxxxxxxxxxx-3-xx-xxxxxxxx-2-xx-1-xx

94723-86-1

425-150-8

1480

Xxxxxxxxxx (XXX); 2-{(XX)-1-[(2XX)-2-(4-xxxxxxxxxxxx) xxxxxxxxxxxx]xxxxx}-3-xxxxxxx-5-(xxxxx-3-xx)xxxxxxxx-2-xx-1-xx

139001-49-3

604-105-8

1481

Xxxxxxxxxxxx (XXX); (XX)-(XX)-2-{1-[(2X)-3-xxxxxxxxxxxxxxxxxx]xxxxxx}-3-xxxxxxx-5-xxxxxxxxxxxxx-4-xxxxxxxxxx-2-xx-1-xx

149979-41-9

604-715-4

1482

3,3-(Xxxxxxxxxxxx)xxxxx-5(10),9(11)-xxxx-17-xx

5571-36-8

427-230-8

1483

Xxxxxxxx-1,4,9(11)-xxxxx-3,17-xxxx

15375-21-0

433-560-3

1484

Xxxxxxx xxxx: xxxxxxx-xxxxxxxxxxxxxxx (xxxxxxxxxx xxxxxx X10-X14 a X18-X30); kalcium-alkylfenoláty (xxxxxxxxxx xxxxxx C10-C14 x X18-X30); xxxxxxx-xxxxxxxxxxxxxxxxxxx (rozvětvené xxxxxx X10-X14 a X18-X30)

—

415-930-6

1485

Xxxxxxxx 1,2-xxxxxxxxxxxxxxxxxxx; dialkyl-(alkyly X6-X8)xxxxxx, xxxxxxxxxx, xxxxxx xx C7

71888-89-6

276-158-1

1486

Reakční xxxx: xxxxxxx 4,4′-xxxxxxxxxxxx[2-(2-xxxxxxx-5-xxxxxxxxxxxx)-3,6-xxxxxxxxxxxxxx] a xxxxxxxx 6-xxxxx-5,6-xxxxxxx-5-xxxxxxxxxxx-1-xxxxxxxxx (1:2); xxxxxxxx 4,4′-xxxxxxxxxxx[2-(2-xxxxxxx-5-xxxxxxxxxxxx)-3,6-xxxxxxxxxxxxxx] a xxxxxxxx 6-diazo-5,6-dihydro-5-oxonaftalen-1-sulfonové (1:3)

—

427-140-9

1487

Xxxxxxxxx 1-xxxxxxx-2-(4-(4-xxxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx)-7-xxxxx-3-xxxxxxxxxxxxxxxx

150202-11-2

422-670-7

1488

Xxxxxxxx 3-oxoandrost-4-en-17-β -xxxxxxxxxxx

302-97-6

414-990-0

1489

Xxxxxxxx (X)-2-xxxxxxxxxxx-2-[2-(xxxxxxxxxxx)xxxxxxx-4-xx]xxxxxx

64485-90-1

431-520-1

1490

Xxxxxxxxxx-xxxxxxxxxxxxxxxx

5064-31-3

225-768-6

1491

2-Xxxxxxxxxx-(2-xxxxxxxxxxxxx)

7425-14-1

231-057-1

1492

Xxxxxxxxxx-xxxxxx

84-69-5

201-553-2

1493

Xxxxxxxxxxxxxxxxxxxxxx kyselina; xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxx xxxxxxxx [1]

1763-23-1 [1]

217-179-8 [1]

xxxxxx-xxxxxxxxxxxxxxxxxxxxx; kalium-heptadekafluoroktan-1-sulfonát [2]

2795-39-3 [2]

220-527-1 [2]

xxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]

70225-14-8 [3]

274-460-8 [3]

amonium-perfluoroktansulfonát; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [4]

29081-56-9 [4]

249-415-0 [4]

xxxxxxx-xxxxxxxxxxxxxxxxxxxxx; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [5]

29457-72-5 [5]

249-644-6 [5]

1494

Xxxxx-[1-(2,4-xxxxxxxxxxxx)5-(xxxxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-3-xxxxxxxxxx]

103112-35-2

401-290-5

1495

1-Xxxx-2-xxxxxxxxxxxxxxxxxxxxx

158894-67-8

422-900-6

1496

1-Xxxxxxxxxxxxxxx-xxxxxxxxxxxxx

99464-83-2

444-950-8

1497

6,6′-Xxx(xxxxx-5,5′,6,6′-xxxxxxxxxx-5,5′-xxxxx)[xxxxxxxxxxx(5-(6-xxxxx-5,6-xxxxxxx-5-xxx-1-xxxxxxxxxxxxxxxxx)-6-xxxxxx-2-xxxxxxx]xx(xxxxxxxx-1-xxxxxxxx)

—

441-550-5

1498

Xxxxxxxxxxx (XXX); α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidin; 2,6-xxxxxxx-X,X-xxxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx; X,X-xxxxxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx

1582-09-8

216-428-8

1499

4-Xxxxx-2-xxxxxxxxxxx

1671-49-4

430-550-0

1500

Xxxxxxxxxx-4-[(4-[1-xxxxxxx-7-(4-xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxx-2-xxxxxx]xxx-2,5-xxxxxxxxxxxxxx)xxx]xxxxxxx

221354-37-6

432-270-4

1501

Xxxxxxx směs: xxxxxxxxxx-6-xxxxx-3-({2,5-xxxxxxxx-4-[(3-xxxxxxxxxxxx)xxx]xxxxx}xxx)-4-xxxxxxxxxxxxxxx-2-xxxxxxxx; diamonium-3-({4-[(7-amino-1-hydroxy-3-sulfo-2-naftyl)azo]-2,5-diethoxyfenyl}azo)benzoát

163879-69-4

438-310-7

1502

N,N′-(bifenyl-4,4′-diyl)bisacetamid

613-35-4

210-338-2

1503

Cyklohexylamin

108-91-8

203-629-0

1504

Piperazin

110-85-0

203-808-3

1505

Hydroxylamin

7803-49-8

232-259-2

1506

Hydroxylamonium-chlorid; xxxxxxxxxxxx-xxxxxxxxxxxx [1]

5470-11-1 [1]

226-798-2 [1]

xxx(xxxxxxxxxxxxxxx-xxxxxx); xxxxxxxxxxxx-xxxxxx (2:1) [2]

10039-54-0 [2]

233-118-8 [2]

1507

Methylfenylendiamin; xxxxxxxxxxxxx

—

—

1508

Xxxxxxxxxxx; 4-xxxxxx-X-xxxxx-6-(1-xxxxxxxx)-2-xxxxxxxxxxxxx

110235-47-7

600-951-7

1509

Xxxxxxxxxxxxxxx-xxxxxxxxxxxxxx; hydroxylamin-sulfát (1:1) [1]

10046-00-1 [1]

233-154-4 [1]

xxxxxxxxxxxx-xxxxxx [2]

20845-01-6 [2]

244-077-0 [2]

hydroxylamin-dihydrogenfosfát [3]

19098-16-9 [3]

242-818-2 [3]

hydroxylamin-4-methylbenzen-1-sulfonát [4]

53933-48-5 [4]

258-872-5 [4]

1510

(3-Xxxxx-2-xxxxxxxxxxxxx)xxxxxxxxxxxxxxxx-xxxxxxx

3327-22-8

222-048-3

1511

Xxxxxxx-3,3′,4,4′-xxxxxxxx; 3,3′-xxxxxxxxxxxxxxx

91-95-2

202-110-6

1512

Xxxxxxxxx-xxxxxxxxxxxx [1]

6094-40-2 [1]

228-042-7 [1]

xxxxxxxxx-xxxxxxxxxxxxxx [2]

142-64-3 [2]

205-551-2 [2]

xxxxxxxxx-xxxxxx [3]

1951-97-9 [3]

217-775-8 [3]

1513

3-(Xxxxxxxxx-1-xx)-xxxxx[x]xxxxxxxxxx-xxxxxxxxxxxx

87691-88-1

421-310-6

1514

(2-Xxxxxxxxxx)xxxxxxxx-xxxxxxxxxxxx

19398-06-2

421-460-2

1515

(2-Xxxxxxxxxx)(3-xxxxxxxxxxxxx)xxxxxxx-xxxxxxx

40722-80-3

429-740-6

1516

4-[(3-Xxxxxxxxxx)(xxxxxxxx-1-xx)xxxxxx]xxxxxx-1,2-xxxxxxxxxxxxxxxxxxxx

159939-85-2

425-030-5

1517

Xxxxx-X,X-xxxxxxxxxxxxxxxxxxx-xxxxxxx

3724-43-4

425-970-6

1518

7-Xxxxxxx-6-[3-(xxxxxxxx-4-xx)xxxxxxx]xxxxxxxxxx-4(3X)-xx;

199327-61-2

429-400-7

1519

Xxxxxxxx reakce bis(2-hydroxypropyl) xxxxx x xxxxxxxxxxxxx (1:4)

220444-73-5

432-440-8

1520

3-Xxxxx-4-[(3-xxxxxxxxxxx)xxx]xxxxxx

202197-26-0

445-590-4

1521

Xxxxxxxxxxxxxx; 3,8-Xxxxxxx-1-xxxxx-6-xxxxxxxxxxxxxxxxxxxx-xxxxxx

1239-45-8

214-984-6

1522

(2XX)-2-xxxxx-3,3-xxxxxxxxxxxxxxxxx

144177-62-8

447-860-7

1523

9-Xxxxxxxxxxxxx-3-xxxx; (9-Xxxxxxxxxxxxx-3-xx)xxxx

132-32-1

205-057-7

1524

(6X-xxxxx)-1-((7-xxxxxx-2-xxxxxxxxxxx-8-xxx-5-xxxx-1-xxxxxxxxxx-[4.2.0]xxx-2-xx-3-xx)xxxxxx)xxxxxxxxxx-xxxxx

100988-63-4

423-260-0

1525

Xxxxxxxxxxxxxxx (XXX); 1-(2-chlor-4-pyridyl)-3-fenylmočovina

68157-60-8

614-346-0

1526

1,3-Dimethyltetrahydropyrimidin-2(1H)-on; dimethylpropylenmočovina

7226-23-5

230-625-6

1527

Chinolin

91-22-5

202-051-6

1528

Ketokonazol; 1-[4-(4-{[(2XX,4XX)-2-(2,4-xxxxxxxxxxxx)-2-(xxxxxxxx-1-xxxxxxxx)-1,3-xxxxxxxx-4-xx]xxxxxxx} xxxxx)xxxxxxxxx-1-xx]xxxxx-1-xx

65277-42-1

265-667-4

1529

Xxxxxxxxxx (ISO); (1XX,5XX;1XX,5XX)-5-(4-xxxxxxxxxxx)-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx

125116-23-6

603-031-3

1530

Xxxxxx-1-xxxxxx-4-{3-[1-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-5-xxx-4,5-xxxxxxxxxxxxxx-4-xxxxxx]xxxx-1-xx-1-xx}-3-(xxxxxxxxxxxxxxxxx)xxxxxxx-5-xxxx

183196-57-8

418-260-2

1531

1,3,5-Xxxx(2,3-xxxxx-2-xxxxxxxxxxxx)-1,3,5-xxxxxxx-2,4,6(1X,3X,5X)-xxxxx

26157-73-3

435-010-8

1532

2,2-Xxx(xxxxxxxxxxxxx)xxxxx-1-xx-xxxx[3-(xxxxxxxx-1-xx)xxxxxxxxx]; (TAZ)

52234-82-9

257-765-0

1533

4,4′-Methylendifenyl xxxxxxxxxxx; xxxxxxxxxxxxx-4,4′-xxxxxxxxxxx [1]

101-68-8 [1]

202-966-0 [1]

2,2′-xxxxxxxxxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxxx-2,2′-xxxxxxxxxxx [2]

2536-05-2 [2]

219-799-4 [2]

x-(x-xxxxxxxxxxxxxxxx)xxxxx xxxxxxxxx; difenylmethan-2,4′-diisokyanát [3]

5873-54-1 [3]

227-534-9 [3]

xxxxxxxxxxxxxxx-xxxxxxxxxxx [4]

26447-40-5 [4]

247-714-0 [4]

1534

Xxxxxxx xxxxx (XXX); xxxxx-(X)-2-xxxxx-3-[2-xxxxx-5-(xxxxxxxx-1-xx-1,2-xxxxxxxxxxxxx)xxxxx]xxxxxxx

142891-20-1

604-318-6

1535

X-[6,9-xxxxxxx-9-[[2-xxxxxxx-1-(xxxxxxxxxxxxx)xxxxxx]xxxxxx]-6-xxx-1X-xxxxx-2-xx]xxxxxxxx

84245-12-5

424-550-1

1536

Xxxxxxxxxxxxx (XXX); (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx

149961-52-4

604-712-8

1537

2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxx

27366-72-9

435-470-1

1538

Xxxxxxx směs: 2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx[X-(2,4-xxxxxxxxxxxxx)-3-xxxxxxxxxxxx]; X-(2,4-xxxxxxxxxxxxx)-X′-(2-xxxxxxxxxxx)-2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx(3-xxxxxxxxxxxx); 2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylfenyl)amino]karbonyl]-2-oxopropyl]azo][1,1′-bifenyl]-4-yl]azo]-N-(2-karboxylfenyl)-3-oxo-butanamid

434-330-5

1539

Ropa, xxxx, xxxxx a xxxxx xxxx x xxxxxx xxxxxxxx generované xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,1 % hmotnostních xxxxxxx

85536-20-5

85536-19-2

90641-12-6

90989-38-1

91995-20-9

92062-36-7

91995-61-8

101316-63-6

93821-38-6

90641-02-4

101316-62-5

90641-03-5

65996-79-4

101794-90-5

90640-87-2

84650-03-3

65996-82-9

90641-01-3

65996-87-4

90640-99-6

68391-11-7

92062-33-4

91082-52-9

68937-63-3

92062-28-7

92062-27-6

91082-53-0

91995-31-2

91995-35-6

91995-66-3

122070-79-5

122070-80-8

65996-78-3

94114-52-0

94114-53-1

94114-54-2

94114-56-4

94114-57-5

90641-11-5

8006-61-9

8030-30-6

8032-32-4

64741-41-9

64741-42-0

64741-46-4

64742-89-8

68410-05-9

68514-15-8

68606-11-1

68783-12-0

68921-08-4

101631-20-3

64741-64-6

64741-65-7

64741-66-8

64741-70-4

64741-84-0

64741-92-0

68410-71-9

68425-35-4

68527-27-5

91995-53-8

92045-49-3

92045-55-1

92045-58-4

92045-64-2

101316-67-0

64741-54-4

64741-55-5

68476-46-0

68783-09-5

91995-50-5

92045-50-6

92045-59-5

92128-94-4

101794-97-2

101896-28-0

64741-63-5

64741-68-0

68475-79-6

68476-47-1

68478-15-9

68513-03-1

68513-63-3

68514-79-4

68919-37-9

68955-35-1

85116-58-1

91995-18-5

93571-75-6

93572-29-3

93572-35-1

93572-36-2

64741-74-8

64741-83-9

67891-79-6

67891-80-9

68425-29-6

68475-70-7

68603-00-9

68603-01-0

68603-03-2

68955-29-3

92045-65-3

64742-48-9

64742-49-0

64742-73-0

68410-96-8

68410-97-9

68410-98-0

68512-78-7

85116-60-5

85116-61-6

92045-51-7

92045-52-8

92045-57-3

92045-61-9

92062-15-2

93165-55-0

93763-33-8

93763-34-9

64741-47-5

64741-48-6

64741-69-1

64741-78-2

64741-87-3

64742-15-0

64742-22-9

64742-23-0

64742-66-1

64742-83-2

64742-95-6

68131-49-7

68477-34-9

68477-50-9

68477-53-2

68477-55-4

68477-61-2

68477-89-4

68478-12-6

68478-16-0

68513-02-0

68516-20-1

68527-21-9

68527-22-0

68527-23-1

68527-26-4

68603-08-7

68606-10-0

68783-66-4

68919-39-1

68921-09-5

85116-59-2

86290-81-5

90989-42-7

91995-38-9

91995-41-4

91995-68-5

92045-53-9

92045-60-8

92045-62-0

92045-63-1

92201-97-3

93165-19-6

94114-03-1

95009-23-7

97926-43-7

98219-46-6

98219-47-7

101316-56-7

101316-66-9

101316-76-1

101795-01-1

102110-14-5

68476-50-6

68476-55-1

90989-39-2

287-502-5

287-500-4

292-636-2

292-694-9

295-281-1

295-551-9

295-323-9

309-868-8

298-725-2

292-625-2

309-867-2

292-626-8

266-013-0

309-971-8

292-609-5

283-483-2

266-016-7

292-624-7

266-021-4

292-622-6

269-929-9

295-548-2

293-766-2

273-077-3

295-543-5

295-541-4

293-767-8

295-292-1

295-295-8

295-329-1

310-170-0

310-171-6

266-012-5

302-688-0

302-689-6

302-690-1

302-692-2

302-693-8

292-635-7

232-349-1

232-443-2

232-453-7

265-041-0

265-042-6

265-046-8

265-192-2

270-077-5

271-025-4

271-727-0

272-186-3

272-931-2

309-945-6

265-066-7

265-067-2

265-068-8

265-073-5

265-086-6

265-095-5

270-088-5

270-349-3

271-267-0

295-315-5

295-430-0

295-436-3

295-440-5

295-446-8

309-871-4

265-055-7

265-056-2

270-686-6

272-185-8

295-311-3

295-431-6

295-441-0

295-794-0

309-974-4

309-987-5

265-065-1

265-070-9

270-660-4

270-687-1

270-794-3

270-993-5

271-008-1

271-058-4

272-895-8

273-271-8

285-509-8

295-279-0

297-401-8

297-458-9

297-465-7

297-466-2

265-075-6

265-085-0

267-563-4

267-565-5

270-344-6

270-658-3

271-631-9

271-632-4

271-634-5

273-266-0

295-447-3

265-150-3

265-151-9

265-178-6

270-092-7

270-093-2

270-094-8

270-988-8

285-511-9

285-512-4

295-432-1

295-433-7

295-438-4

295-443-1

295-529-9

296-942-7

297-852-0

297-853-6

265-047-3

265-048-9

265-071-4

265-079-8

265-089-2

265-115-2

265-122-0

265-123-6

265-170-2

265-187-5

265-199-0

268-618-5

270-725-7

270-735-1

270-736-7

270-738-8

270-741-4

270-771-8

270-791-7

270-795-9

270-991-4

271-138-9

271-262-3

271-263-9

271-264-4

271-266-5

271-635-0

271-726-5

272-206-0

272-896-3

272-932-8

285-510-3

289-220-8

292-698-0

295-298-4

295-302-4

295-331-2

295-434-2

295-442-6

295-444-7

295-445-2

296-028-8

296-903-4

302-639-3

305-750-5

308-261-5

308-713-1

308-714-7

309-862-5

309-870-9

309-879-8

309-976-5

310-012-0

270-690-8

270-695-5

292-695-4

1540

Xxxx, uhlí, xxxxx x xxxxx xxxx x jejich xxxxxxxx xxxxxxxxxx xx použití xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,005 % xxxxxxxxxxxx xxxxx[x]xxxxxx

90640-85-0

92061-93-3

90640-84-9

61789-28-4

70321-79-8

122384-77-4

70321-80-1

292-606-9

295-506-3

292-605-3

263-047-8

274-565-9

310-189-4

274-566-4

1541

Xxxx, xxxx, xxxxx x xxxxx xxxx a xxxxxx deriváty generované xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx metod xxxxxxxxxx, xxxxx obsahují ≥ 0,1 % xxxxxxxxxxxx benzenu xxxx xxxxx obsahují ≥ 0,005 % xxxxxxxxxxxx xxxxx[x]xxxxxx

85029-51-2

84650-04-4

84989-09-3

91995-49-2

121620-47-1

121620-48-2

90640-90-7

90641-04-6

101896-27-9

101794-91-6

91995-48-1

90641-05-7

84989-12-8

121620-46-0

90640-81-6

90640-82-7

92061-92-2

91995-15-2

91995-16-3

91995-17-4

101316-87-4

122384-78-5

84988-93-2

90640-88-3

65996-83-0

90640-89-4

90641-06-8

65996-85-2

101316-86-3

92062-22-1

96690-55-0

84989-04-8

84989-05-9

84989-06-0

84989-03-7

84989-07-1

68477-23-6

68555-24-8

91079-47-9

92062-26-5

94114-29-1

90641-00-2

68513-87-1

70321-67-4

92062-29-8

100801-63-6

100801-65-8

100801-66-9

73665-18-6

68815-21-4

65996-86-3

65996-84-1

285-076-5

283-484-8

284-898-1

295-310-8

310-166-9

310-167-4

292-612-1

292-627-3

309-985-4

309-972-3

295-309-2

292-628-9

284-901-6

310-165-3

292-603-2

292-604-8

295-505-8

295-275-9

295-276-4

295-278-5

309-889-2

310-191-5

284-881-9

292-610-0

266-017-2

292-611-6

292-629-4

266-019-3

309-888-7

295-536-7

306-251-5

284-892-9

284-893-4

284-895-5

284-891-3

284-896-0

270-713-1

271-418-0

293-435-2

295-540-9

302-662-9

292-623-1

271-020-7

274-560-1

295-544-0

309-745-9

309-748-5

309-749-0

277-567-8

272-361-4

266-020-9

266-018-8

1542

Xxxx, xxxx, xxxxx x xxxxx plyn x xxxxxx deriváty xxxxxxxxxx za xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx zpracování, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx buta-1,3-dienu

68607-11-4

68783-06-2

68814-67-5

68814-90-4

68911-58-0

68911-59-1

68919-01-7

68919-02-8

68919-03-9

68919-04-0

68919-07-3

68919-08-4

68919-11-9

68919-12-0

68952-79-4

68952-80-7

68955-33-9

68989-88-8

92045-15-3

92045-16-4

92045-17-5

92045-18-6

92045-19-7

92045-20-0

68131-75-9

68307-98-2

68307-99-3

68308-00-9

68308-01-0

68308-10-1

68308-03-2

68308-04-3

68308-05-4

68308-06-5

68308-07-6

68308-09-8

68308-11-2

68308-12-3

68409-99-4

68475-57-0

68475-58-1

68475-59-2

68475-60-5

68476-26-6

68476-29-9

68476-40-4

68476-42-6

68476-49-3

68476-85-7

68476-86-8

68477-33-8

68477-35-0

68477-69-0

68477-70-3

68477-71-4

68477-72-5

68308-08-7

271-750-6

272-182-1

272-338-9

272-343-6

272-775-5

272-776-0

272-873-8

272-874-3

272-875-9

272-876-4

272-880-6

272-881-1

272-884-8

272-885-3

273-173-5

273-174-0

273-269-7

273-563-5

295-397-2

295-398-8

295-399-3

295-400-7

295-401-2

295-402-8

268-629-5

269-617-2

269-618-8

269-619-3

269-620-9

269-630-3

269-623-5

269-624-0

269-625-6

269-626-1

269-627-7

269-629-8

269-631-9

269-632-4

270-071-2

270-651-5

270-652-0

270-653-6

270-654-1

270-667-2

270-670-9

270-681-9

270-682-4

270-689-2

270-704-2

270-705-8

270-724-1

270-726-2

270-750-3

270-751-9

270-752-4

270-754-5

269-628-2

1543

Tris[2-chlor-1-(chlormethyl)ethyl]fosfát

13674-87-8

237-159-2

1544

Fosfid xxxxx

22398-80-7

244-959-5

1545

Xxxxxxxx-xxxxxx

25155-23-1

246-677-8

1546

Xxxxxxxxxxxxxxxxxxxx [1]

25637-99-4 [1]

247-148-4 [1]

1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxx [2]

3194-55-6 [2]

221-695-9 [2]

1547

Xxxxxxxxxxxxxxx

109-99-9

203-726-8

1548

Xxxxxxxxx (směs xxxxxxxxxxx X1x x avermektinu X1x) (ISO) [1]

71751-41-2 [1]

615-339-5 [1]

xxxxxxxxxx X1x [2]

65195-55-3 [2]

265-610-3 [2]

1549

4-Xxxx-xxxxxxxxxxxxx xxxxxxxx

98-73-7

202-696-3

1550

Xxxxxxxxxxxxxxxx xxxxx; X,X,X′,X′-xxxxxxxxxxx-4,4′-xxxxxxxxxxxxxxxxxx

129-73-7

204-961-9

1551

Xxxxxxxxxxx (XXX); 2-(2-furyl)benzimidazol

3878-19-1

223-404-0

1552

Metazachlor (ISO); 2-xxxxx-X-(2,6-xxxxxxxxxxxxx)-X-(xxxxxxx-1-xxxxxxxx)xxxxxxxx

67129-08-2

266-583-0

1553

Xx-xxxx-xxxxxxxxxxxx

110-05-4

203-733-6

1554

Xxxxxxxxxxxxxxxxxxxxx

993-16-8

213-608-8

1555

2-Xxxxxxxxxx-10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx

57583-34-3

260-828-5

1556

2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)

15571-58-1

239-622-4

1557

Xxxxxxxxxx (XXX); 2-[2-xxxxx-4-(xxxxxxxxxxxxxx)xxxxxxx]xxxxxxxxxx-1,3-xxxx

99105-77-8

619-394-6

1558

Xxxxxxxxxx (XXX); (2-xxxxxxxxxxxxx-3-xx)xxxxxx-xxx-(1X,3X)-3-[(1X)-2-xxxxx-3,3,3-xxxxxxxxxxxx-1-xx-1-xx]-2,2-xxxxxxxxxxxxxxxxxxx-xxxxxxxxxx

82657-04-3

617-373-6

1559

Xxxxxxx-xxxxxx

84-75-3

201-559-5

1560

Xxxxxxx-xxxxxxxxxxxxxxxxxxxxxx

3825-26-1

223-320-4

1561

Xxxxxxxxxxxxxxxx xxxxxxxx

335-67-1

206-397-9

1562

X-xxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxx-2-xx

2687-91-4

220-250-6

1563

Xxxxxxxxxxx (XXX); 6-jod-2-propoxy-3-propylchinazolin-4(3H)-on

189278-12-4

606-168-7

1564

Arsenid xxxxx

1303-00-0

215-114-8

1565

Xxxxx-xxxxxx

108-05-4

203-545-4

1566

Xxxxxxxxx (ISO); 2-chlor-3-fenoxy-6-nitroanilin

74070-46-5

277-704-1

1567

2-Ethylhexyl-(10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradekanoát)

57583-35-4

260-829-0

1568

Dimethylstannan-dichlorid

753-73-1

212-039-2

1569

4-Vinylcyklohexen

100-40-3

202-848-9

1570

Tralkoxydim (XXX); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyklohex-2-en-1-on

87820-88-0

618-075-9

1571

Cykloxydim (XXX); 2-(X-xxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-(xxxxxxxxxx-2X-xxxxxxxxx-3-xx)xxxxxxxx-2-xx-1-xx

101205-02-1

405-230-9

1572

Xxxxxxxxx (XXX); 3-xxxxx-X-[3-xxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxx]-5-(xxxxxxxxxxxxxx)xxxxxxx-2-xxxx

79622-59-6

616-712-5

1573

Xxxxxxxxxx (XXX); 1-[2-(2,4-xxxxxxxxxxxx)xxxxxx]-1X-1,2,4-xxxxxxx

66246-88-6

266-275-6

1574

Xxxxxxxxxx (XXX); xxxxx-X-[2-(4-xxxxxxxxxxxx)xxxxx]xxxxxxxx

72490-01-8

276-696-7

1575

Xxxxxx

100-42-5

202-851-5

1576

2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxx

97-99-4

202-625-6

1577

Xxxxxxxxxxx

50-00-0

200-001-8

1578

Xxxxxxxxxxxxxxx

30525-89-4

608-494-5

1579

Xxxxxxxxxx, xxxxxxxxxxxxxx

463-57-0

207-339-5

1580

Xxxxxxxxx (XXX); 1-ethyl-3-[2-kyan-2-(methoxyimino)acetyl]močovina

57966-95-7

261-043-0

1581

Tributylstannan, sloučeniny

—

—

1582

Tembotrion (XXX); 2-{2-chlor-4-(methylsulfonyl)-3-[(2,2,2-trifluorethoxy)methyl]benzoyl}cyklohexan-1,3-dion

335104-84-2

608-879-8

1583

1,2-Benzendikarboxylová kyselina, xxxxxxxxxxxx, rozvětvený x xxxxxxxx

68515-50-4

271-093-5

1584

Xxxxxxxxxxxxx (ISO); (5x,8x)-3-(2,5-xxxxxxxxxxxxx)-8-xxxxxxx-2-xxx-1-xxxxxxxx[4,5]xxx-3-xx-4-xx-xxxxxxxxxxxxx

203313-25-1

606-523-6

1585

Xxxxxxxx-xxxxxx; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx

31717-87-0

250-778-2

1586

Xxxxxxxxxxxxxx-xxxxxx; xxxxxx-2-([4-(xxxxxxxxxxxxx)-6-(2,2,2-xxxxxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxxxxxx

126535-15-7

603-146-9

1587

Xxxxxxxx (XXX); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx

35554-44-0

252-615-0

1588

Xxxxxxxx (ISO); 4-xxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx

1593-77-7

216-474-9

1589

Xxxxxxxx

288-32-4

206-019-2

1590

Xxxxxxx (XXX); 3-xxxxxxxxxx-6,7-xxxxxxx-1X-xxxxxxxxxx[x]xxxxxxxxx-2,4(3X,5X)-xxxx

2164-08-1

218-499-0

1591

Xxxxxxxxx (XXX); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx

139528-85-1

604-145-6

1592

2-Xxxxxx-1-(4-xxxxxxxxxxxxxxx)-2-xxxxxxxxxxxxxxx 1-xx

71868-10-5

400-600-6

1593

2,3-Xxxxxxxxxxx-xxxxxxxxxxx

106-91-2

203-441-9

1594

Xxxxxxxxxx (XXX) 8-xxxx-xxxxx-1,4-xxxxxxxxxx[4.5]xxxxx-2-xxxxxxxx(xxxxx)(xxxxxx)xxxx

118134-30-8

601-505-4

1595

Xxxxxxxx; xxxxxxxxxxx

420-04-2

206-992-3

1596

Xxxxxxxxxxxx (XXX); (2XX,3XX;2XX,3XX)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxx-2-xx

94361-06-5

619-020-1

1597

Xxxxxxxx-xxxxxxxxx xxxxxx

130328-20-0

603-404-0

1598

Xxxxxxxxx xxxxxxxxx

513-78-0

208-168-9

1599

Xxxxxxxx xxxxxxxxx

21041-95-2

244-168-5

1600

Xxxxxxxx kademnatý

10325-94-7

233-710-6

1601

Dibutylcín-dilaurát xxxxxxx[xxx(xxxxxxxxxxxxx)]xxxxxxx

77-58-7

201-039-8

1602

Xxxxxxxxx; 2-xxxxxx-4-xxxxxxxxxx

120-32-1

204-385-8

1603

Xxxxxxxxxxxx

84-65-1

201-549-0

1604

Xxxxxxxxxxxxxxxxxxxxx xxxxxxxx [1]

335-76-2 [1]

206-400-3[1]

xxxxxxx-xxxxxxxxxxxxxxxxxxxxx [2]

3108-42-7 [2]

221-470-5 [2] [3]

sodium-nonadekafluordekanoát [3]

3830-45-3 [3]

1605

X,X′-xxxxxxxxxxxxxxxxxx; X,X′-xxxxxxxxxxxxxxxxxxx; [xxxxxxxxxxx xxxxxxxx x N,N′-methylenebismorfolinu]; [XXX]

xxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxx xx xxxxx xx xx xxxxx, jak xx xxxxxxx xx trh, ≥ 0,1 % xxxxxxxxxxxx

5625-90-1

227-062-3

1606

Xxxxxxx xxxxxxxx paraformaldehydu x 2-xxxxxxxxxxxxxxxxxxx (3:2);

[xxxxxxxxxxx xxxxxxxx x 3,3′-xxxxxxxxxxx [5–xxxxxxxxxxxxxxxxx]; [formaldehyd uvolněný x oxazolidinu]; [MBO], xxxxx maximální teoretická xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx xxx xxxxxx xx xxxxx je ve xxxxx, xxx je xxxxxxx xx xxx, ≥ 0,1 % xxxxxxxxxxxx

—

—

1607

Xxxxxxx xxxxxxxx xxxxxxxxxxxxxxxx x 2-xxxxxxxxxxxxxxxxxxx (1:1);

[xxxxxxxxxxx xxxxxxxx x α,α,α-trimethyl-1,3,5-triazin-1,3,5 (2X,4X,6X)-xxxxxxxxxxx]; [XXX], xxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx bez xxxxxx xx zdroj xx xx xxxxx, xxx xx xxxxxxx xx trh, ≥ 0,1 % hmotnostních

—

—

1608

Methylhydrazin

60-34-4

200-471-4

1609

Triadimenol (XXX); (1XX,2XX;1XX,2XX)-1-(4-xxxxxxxxxxx)-3,3-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxx-2-xx); α-xxxx-xxxxx-β-(4-xxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-1-xxxxxxx

55219-65-3

259-537-6

1610

Xxxxxxxxxxx (XXX); (X)-3-(6-xxxxx-3-xxxxxxxxxxxxx)-1-3-xxxxxxxxxxx-2-xxxxxxxxxxxxxx; {(2Z)-3-[(6-chlorpyridin-3-yl)methyl]-1,3-thiazolidin-2-yliden}kyanamid

111988-49-9

601-147-9

1611

Karbetamid (XXX); (R)-1-(ethylkarbamoyl)ethylkarbanilát (2R)-1-(ethylamino)-1-oxopropan-2-yl-fenylkarbamát

16118-49-3

240-286-6“

b)

položka 395 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx XXX

Xxxxx XX

„395

Xxxxxxxx-8-xx x xxxx sulfát

148-24-2

134-31-6

205-711-1

205-137-1“

2)   

Příloha XXX xx mění xxxxx:

x)

xxxxxxx 1a, 1b, 7, 13 a 51 xx xxxxxxx;

x)

xxxxxxx 12 xx xxxxxxxxx tímto:

Referenční xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxx

Xxxxx xxxxxxxx xxxxxxx x upozornění

Chemický xxxxx/XXX

Xxxxx x seznamu xxxxxx xxxxx společné xxxxxxxxxxxx

Xxxxx XXX

Xxxxx XX

Xxxx xxxxxxx, xxxxx těla

Nejvyšší xxxxxxxxxxx v xxxxxxxxx xxxxxxxxxxx x použití

Jiné

a

b

c

d

e

f

g

h

i

„12

Peroxid xxxxxx x ostatní xxxxxxxxxx xxxx xxxxx, xxxxx peroxid xxxxxx xxxxxxxx, xxxxxx xxxxx xxxxxxxx peroxid x xxxxxxx xxxxxxxxx, x xxxxxxxx těchto xxxxx x xxxxxxx II:

—

č. 1397, 1398, 1399

Hydrogen xxxxxxxx

7722-84-1

231-765-0

x)

Xxxxxxxxx xx xxxxx

x)

12 % X2X2 (40 xxxxxx), xxxxxxxxxx nebo xxxxxxxxxx

x) f) Xxxxxxxxxx xxxxxx xxxxxxxx.

x) b) x) x)

Xxxxxxxx peroxid xxxxxx.

Xxxxxxxx xxxxx s xxxxx.

Xxx zasažení xxx xxxxxxxx xxxxxxxxxxx vodou.

b)

Přípravky xx xxxx

x)

4 % X2X2, xxxxxxxxxx nebo xxxxxxxxxx

x)

Xxxxxxxxx pro xxxxxxx xxxxx

x)

2 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)

Xxxxxxxxx xxx xxxxx hygienu, xxxxxx ústní vody, xxxxx xxxxx a xxxxxxxxx na bělení xxxx xxxxxxxxxx xxxx

x)

≤ 0,1 % H2O2, xxxxxxxxxx nebo xxxxxxxxxx

x)

Xxxxxxxxx xx xxxxxx xxxx xxxxxxxxxx zubů

e)

> 0,1 % ≤ 6 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)

X xxxxxxx xxxxx xxxxxx lékařům. X xxxxxxx xxxxx xxxxxxx xxxx xxx xxxxx použití xxxxxxxxx xxxxxx xxxxxxx xx xxxxxx směrnice Evropského xxxxxxxxxx x Xxxx 2005/36/XX&xxxx;(*1) xxxx xxx xxxx xxxxxx dohledem, xxxxx je zaručena xxxxxxxxxx xxxxxx xxxxxxxxxxx.

Xxxx xxxxxx xxxxxxxxxxxx k xxxxxxxxx xxxxx xxxxxxx.

Xxxxxxxxxx x osob mladších 18 let.

e)

Koncentrace X2X2 xxxxxxxxxx nebo uvolněného xxxxxxx x xxxxxxxxxx.

Xxxxxxxxxx x xxxx mladších 18 xxx.

X xxxxxxx xxxxx zubním xxxxxxx. X každého xxxxx xxxxxxx xxxx xxx xxxxx xxxxxxx xxxxxxxxx xxxxx zubním lékařem xxxx xxx jeho xxxxxx dohledem, pokud xx xxxxxxxx rovnocenná xxxxxx xxxxxxxxxxx.

Xxxx xxxxxx xxxxxxxxxxxx x xxxxxxxxx xxxxx xxxxxxx.

x)

Xxxxxxxxx xxxxxx xxx xxxx

x)

2 % X2X2, přítomného xxxx xxxxxxxxxx

x)

Xxx pro xxxxxxxxxxxxx xxxxxxx.

x)

Xx xxxxxxx se xxxxx:

„Xxx pro xxxxxxxxxxxxx xxxxxxx.

Xxxxxxxx styku x xxxxx.

Xxx zasažení xxx xxxxxxxx vypláchněte xxxxx.

Xxxxxxxx xxxxxxx vodíku.“

c)

doplňují xx xxxx položky, xxxxx xxxxx:

Xxxxxxxxxx číslo

Identifikace xxxxx

Xxxxxxx

Xxxxx xxxxxxxx xxxxxxx a xxxxxxxxxx

Xxxxxxxx xxxxx/

XXX

Xxxxx v xxxxxxx xxxxxx podle xxxxxxxx xxxxxxxxxxxx

Xxxxx CAS

Číslo XX

Xxxx xxxxxxx, části xxxx

Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx xxxxxxxxxxx x xxxxxxx

Xxxx

x

x

x

x

x

x

x

x

x

„311

Xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx

Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx

75980-60-8

278-355-8

Xxxxxxx umělých xxxxx

5,0 %

Xxxxxxxxxxxxx použití

Jen pro xxxxxxxxxxxxx xxxxxxx.

Xxxxxxxx xxxxx x xxxx.

Xxxxx xxxxxxx xxxxx k použití.

312

2-Furaldehyd

Furfural

98-01-1

202-627-7

0,001 %“

3)&xxxx;&xxxx;&xxxx;

Xxxxxxx X&xxxx;xx xxxx xxxxx:

x)

x&xxxx;xxxxx xx xxx 2 nahrazuje xxxxx:

„2.

 Xxxxxxx xxxxxxx xxxxxxx obsahující xxxxx xxxxxxx x&xxxx;xxxx xxxxxxx, z nichž xx xxxxxxxx xxxxxxxxxxx, xxxx xxx xxxxxxxx upozorněním „xxxxxxxx xxxxxxxxxxx“, jestliže xxxxxxxxxxx formaldehydu v konečném xxxxxxx xxxxxxxx 0,05&xxxx;%.“;

x)

xxxxxxx 5, 31, 40 x&xxxx;41 xx zrušují;

c)

položka 28 xx xxxxxxxxx xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx látky

Podmínky

Znění xxxxxxxx použití x xxxxxxxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx v xxxxxxx xxxxxx xxxxx xxxxxxxx nomenklatury

Číslo XXX

Xxxxx XX

Xxxx výrobku, xxxxx xxxx

Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx připraveném x xxxxxxx

Xxxx

x

x

x

x

x

x

x

x

x

„28

Xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx

Xxxxxxxxxxxxxxx biguanide

32289-58-0,

27083-27-8,

28757-47-3,

133029-32-0

608-723-9

608-042-7

0,1 %

Nepoužívat x xxxxxxxxxx, xxx xxxxx vést x xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx xxx vdechování.“

(*1)  Směrnice Xxxxxxxxxx parlamentu x Xxxx 2005/36/ES xx xxx 7. xxxx 2005 o uznávání xxxxxxxxx kvalifikací (Xx. xxxx. X&xxxx;255, 30.9.2005, x.&xxxx;22).“